Emerging markets, while definitely attractive, can be challenging for Western pharmaceutical companies. Complex legislature, quickly-changing operational environment, and scarcity of reliable information can all pose obstacles to successful commercial activities. Very often local insight is required to develop optimal strategies and to provide effective execution. Raifarm relies on its unique and extensive experience on emerging pharmaceutical markets and its Western business culture to develop optimal solutions for its clients.

We provide a full range of fully-customized consulting solutions to fulfill needs of our clients. Our services include:

• Market analysis. While operating on emerging markets, international companies often encounter market data that is incomplete, unreliable, or contradictory. Raifarm utilized its deep knowledge of local markets, strong network of key opinion leaders, and its proprietary knowledge database to collect and verify information. We analyze data and provide our clients with clear, reliable and actionable results and conclusions. We conduct market analyses in all markets where we operate; our projects are always perfectly tailored for our clients and cover all major therapeutic areas. We already successfully completed more than 25 market analysis projects for leading Western pharmaceutical manufacturers; these assignments covered both new launches and in-line products.

• Strategic advisory. Right strategic advice can be extremely important for successful operations on an emerging market. Yet large international consulting companies very often have limited experience in such specialized and complex industry as pharmaceuticals. We rely on decades of combined industry experience of our employees to fully understand our clients’ needs and to offer reliable, relevant, and executable solutions. Our projects cover a wide range of strategic and operational issues and can easily span across multiple geographies. We successfully completed several consulting projects in the past year that ranged from creation of a CIS market entrance strategy, to drug portfolio optimization, to assessment of a distribution system, and to evaluation of business development opportunities

• In-licensing support. Our employees have exceptionally strong knowledge of various therapeutic areas and drugs available for treatment of different diseases. We utilize this knowledge to identify promising molecules with strong commercial potential. Then we help our clients to source them on best terms. We also maintain a database of selected molecules; we offer them to our clients based on their needs and existing product portfolios. Presently we successfully work with a few large Western companies under this scheme.

• Custom projects. We are able to effectively assist our clients with other advisory services and to offer custom-tailored solutions. Please contact us and we will be happy to offer our expertise.